Qualifying Therapeutic Discovery Project Grants for the State of Rhode Island
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| BCR Diagnostics, Inc. | Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing | $ 158,237.00 | $ 46,393.00 |
| Beech Tree Labs, Inc. | BTL-ng for a Reduction in Nicotine Craving | $ 30,636.00 | $ 133,237.50 |
| Calmar Pain Relief, LLC | Calmar Pain Relief Therapy- pain clinics | $ 51,501.00 | $ 192,978.25 |
| Collegium Pharmaceutical, Inc | COL-003 Extended-Release, Tamper-Resistant Opiod ("COL-003") | $ 244,479.24 | |
| EpiVax, Inc. | EpiVax Therapeutic HIV Vaccinc | $ 26,625.06 | $ 11,344.20 |
| EpiVax, Inc. | Development of Tregitopes as a Novel Therapeutic for Immune Modulation | $ 64,778.30 | $ 149,973.96 |
| IlluminOss Medical Inc | Photodynamic Therapeutic Bone Stabilization System | $ 244,479.25 | |
| In Cytu Inc | Late Stage Melanoma Vaccine Development | $ 244,479.24 | |
| In Cytu, Inc. | Early (Stage I/II) Melanoma Cancer Vaccine Development | $ 126,434.50 | |
| In Cytu, Inc. | Lung Cancer Vaccine Development | $ 3,105.00 | $ 25,374.50 |
| InCytu, Inc. | Glioma Cancer Vaccine Development | $ 21,062.00 | $ 94,239.00 |
| ISIS BIOPOLYMER, INC | ISIS Patch | $ 244,479.25 | |
| MultiCell Technologies Inc | MCT-475 | $ 26,551.00 | $ 217,928.24 |
| MultiCell Technologies, Inc | MCT-465 | $ 159,305.00 | $ 85,174.24 |
| MultiCell Technologies, Inc | MCT-125 | $ 244,479.24 | |
| MYOMICS, INC | Treatment of skeletal muscle weakness and fatique disorders with MYO13 | $ 208,970.50 | $ 35,508.74 |
| NABsys, Inc. | Development of Clinically Relevant DNA Sequencing Technology | $ 244,479.25 | |
| Neurotech USA Inc | NT-502 | $ 244,479.24 | |
| Neurotech USA Inc | NT-501 | $ 244,479.24 | |
| Neurotech USA, Inc | NT-503 | $ 244,479.24 | |
| PROTHERA BIOLOGICS LLC | Therapeutic Tole of Inter-Alpha Inhibitor Proteins | $ 78,475.50 | $ 166,003.75 |
| Rhode Island Mood & Memory Research Institute | Rhode Island Mood & Memory Research Institute | $ 123,308.50 | |
| Tivorsan Pharmaceuticals Inc. | Biglycan for the Treatment of Duchenne Muscular Dystrophy | $ 75,423.88 | $ 169,055.37 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-15
